Skip to main content
OpenTrials
Completed

NCT Number: NCT01565642

Goals of Care: A Nursing Home Trial of Decision Support for Advanced Dementia

This cluster randomized controlled trial is to examine whether decision support for goals of care can improve quality of communication and decision-making and improve the quality of palliative care for nursing home residents with advanced dementia.

Completed

Looking for future studies?

Notify Me

Key information

Age range

65 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University of North Carolina

Chapel Hill, North Carolina, 27599, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Surrogate for nursing home resident with advanced dementia, paired with resident with advanced dementia

Exclusion criteria

  • Non-related legal surrogate without personal knowledge of resident

Treatment and study plan

Goals of care decision support

Behavioral

Decision aid and care plan meeting

Primary outcomes

  1. Quality of Communication and Decision-making

    Time frame: 3 months

    The Quality of Communication (QOC) score with its End of Life (EOL) subscale score. Scores range 0-10 on QOC and its subscales, with higher scores indicating better communication quality.

Secondary outcomes

  1. Number of Palliative Care Domains in Care Plan

    Time frame: 9 months

    Index score ranging from 0-10 with one point given for care plan addressing each domain: prognosis, goals of care, physical symptoms, emotional needs, spiritual needs, resuscitation, artificial feeding, intravenous fluids, antibiotics, hospitalization. Higher scores indicate better palliative care.

  2. Satisfaction With Care

    Time frame: 9 months

    Satisfaction with Care at the End of Life in Dementia (SWC-EOLD) scale; 10 items rated 1-4 and summed with total potential range 10-40. Higher scores indicate better satisfaction.

  3. Comfort in Dying

    Time frame: 9 months

    Comfort Assessment in Dying for Dementia (CAD-EOLD) includes 14 items rated on a 3 point scale, summed for a total potential score of 14-42. Higher scores indicate better comfort.

  4. Alzheimer Disease Related Quality of Life

    Time frame: 9 months

    The Alzheimer Disease Related Quality of Life scale (ADRQL) ranges from 0-100 with higher scores indicating better quality of life.

  5. Quality of Dying

    Time frame: 9 months

    Quality of Dying in Long-term Care (QOD-LTC) instrument has 11 items in 3 subscales measuring personhood, closure and preparation for dying, for total scores ranging 5-55. Higher scores indicate better quality of the dying experience.

  6. Frequency of Communication

    Time frame: 9 months

    Number of participants who report discussions of goals of care with providers -- physicians, nurse practitioners, physician assistants or nursing home staff -- counted during follow-up

  7. Hospice Referral

    Time frame: 9 months

    Number of participants with a referral to hospice services

  8. Hospitalizations

    Time frame: 9 months

    Number and timing of transfer to hospital from nursing home care, measured as hospital transfers per 90 person-days of follow-up, with follow-up censored at death.

Sponsors and collaborators

Lead sponsor

University of North Carolina, Chapel Hill

Other

Collaborators

  • National Institute on Aging (NIA)

Registry information

Acronym: GOC

Important dates

Study start
2012
Primary completion
2015
Study completion
2015
First posted
Mar 28, 2012
Registry last updated
Aug 10, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.